Autolus Therapeutics plc
AUTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$220,662 | -$208,383 | -$148,839 | -$142,096 |
| Dep. & Amort. | $7,716 | $6,565 | $7,422 | $8,458 |
| Deferred Tax | -$185 | -$986 | -$268 | -$72 |
| Stock-Based Comp. | $15,472 | $11,204 | $12,014 | $9,937 |
| Change in WC | -$23,655 | $292 | $3,968 | $4,138 |
| Other Non-Cash | $15,043 | $45,721 | $13,395 | $1,774 |
| Operating Cash Flow | -$206,271 | -$145,587 | -$112,308 | -$117,861 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22,075 | -$10,986 | -$10,841 | -$8,857 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$359,733 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$12,744 | $0 | $0 | $0 |
| Investing Cash Flow | -$394,552 | -$10,986 | -$10,841 | -$8,857 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $549,977 | $0 | $163,854 | $245,900 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $39,577 | -$883 | $59,756 | $38,163 |
| Financing Cash Flow | $589,554 | -$883 | $223,610 | $284,063 |
| Forex Effect | -$261 | $15,030 | -$28,376 | -$754 |
| Net Chg. in Cash | -$11,530 | -$142,426 | $72,085 | $156,591 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $240,335 | $382,761 | $310,676 | $154,085 |
| End Cash | $228,805 | $240,335 | $382,761 | $310,676 |
| Free Cash Flow | -$241,090 | -$156,573 | -$123,149 | -$126,718 |